Find News

Filter articles

Applied Filters

Showing 41 to 50 of 730 results

Boehringer teams up with Gubra to develop second obesity treatment

Denmark, Germany30-05-2019

German pharmaceutical company Boehringer Ingelheim has entered into a second licence and collaboration agreement with Danish biotech company Gubra for the development of an obesity treatment.

Celgene takes action against alleged cybersquatter


US biotechnology company Celgene has taken legal action against the registrant of a domain name which allegedly infringes Celgene’s trademarks.

BGI takes Illumina to court over patent infringement in US

Denmark, Germany, US29-05-2019

A subsidiary of China-based genome sequencing company BGI has filed a patent infringement suit against a US competitor.

University of California granted fifth CRISPR patent


The US Patent and Trademark Office has issued a new CRISPR/Cas9 patent to the University of California, the University of Vienna and microbiologist Emmanuelle Charpentier.

Alphabet's Verily in digital research alliance with Pfizer and others


Verily, which is a subsidiary of Google’s parent company Alphabet, yesterday announced that it had partnered with Novartis, Otsuka, Pfizer, and Sanofi in efforts to develop digitally-innovative clinical research programmes.

Genentech enters agreement to develop autoimmune therapies


US-based biopharmaceutical company Parvus Therapeutics has entered into a collaboration and licensing agreement with Genentech, a subsidiary of Roche.

Google fund invests in CRISPR start-up


Alphabet-owned GV has invested in Verve Therapeutics, a cardiovascular company developing gene editing therapies aiming to permanently reduce the risk of coronary artery disease.

Diabetics to benefit under latest FDA biosimilar guidance


The Food and Drug Administration has issued final guidance on the pathway for ‘interchangeable’ biosimilar products, in a bid to promote competition in the biologics market.

Federal Circuit backs Sandoz in Amgen biosimilar suit


The US Court of Appeals for the Federal Circuit yesterday, May 8, rejected an appeal from Amgen in patent litigation relating to two Sandoz biosimilars.

Lundbeck to acquire Abide Therapeutics for $250 million


Danish pharmaceutical company Lundbeck will acquire Abide Therapeutics, it has been announced.

Showing 41 to 50 of 730 results